Overview

Clozapine Versus Chlorpromazine for Treatment-Unresponsive Schizophrenia

Status:
Terminated
Trial end date:
2002-02-01
Target enrollment:
Participant gender:
Summary
This study will examine the physical response to clozapine or chlorpromazine in people with schizophrenia that has not improved with treatment.
Phase:
Phase 4
Details
Lead Sponsor:
Harvard Medical School
Harvard Medical School (HMS and HSDM)
Collaborators:
Commonwealth Research Center, Massachusetts
Dartmouth-Hitchcock Medical Center
National Institute of Mental Health (NIMH)
Novartis
Treatments:
Chlorpromazine
Clozapine